Evidence map›Paper›PMID 34131150›Full record

ArticleNPJ vaccines2021

The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control.

Kirsten S Vannice, Susan L Hills, Lauren M Schwartz, Alan D Barrett, James Heffelfinger, Joachim Hombach, G William Letson, Tom Solomon, Anthony A Marfin, Japanese encephalitis vaccination experts panel

Abstract read
In one paragraph

Article in NPJ vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. An Updated Review of Potential Drug Targets for Japanese Encephalitis.Central nervous system agents in medicinal chemistry · 2026
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. LncRNAJournal of virology · 2025
    Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kirsten S VanniceConsultant, PATH, Seattle, WA, USA.
Susan L HillsArboviral Diseases Branch, Centers for Disease Control and Prevention, Fort Collins, CO, USA.
Lauren M SchwartzSchwartz Consulting, Seattle, WA, USA.
Alan D BarrettSealy Institute for Vaccine Sciences, Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, USA.
James HeffelfingerWHO Regional Office for the Western Pacific, Manila, Philippines.
Joachim HombachDepartment of Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
G William LetsonPATH, Seattle, WA, USA.
Tom SolomonNational Institute for Health Research Health Protection Research Unit in Emerging and Zoonotic Infections, and Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.
Anthony A MarfinPATH, Seattle, WA, USA. aamarfin@path.org.
Japanese encephalitis vaccination experts panel

Funding

World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34131150
PMCPMC8206071

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.